IDEXX LABORATORIES INC /DE
IDXX evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for IDXX—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 3 of 6 signals
Limited data coverage
Market Cap
$44.34B
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Mar 31, 2026.
Run IDEXX LABORATORIES INC /DE through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available IDEXX LABORATORIES INC /DE facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 3 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 1.18 · 1% dilution
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
0 buys · 1 sell (180d)
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
1,303
Total value held
$40.38B
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 10,365,014 | $5.82B |
| blackrock, inc. | 8,365,553 | $4.70B |
| vanguard portfolio management llc | 3,910,863 | $2.20B |
| state street corp | 3,674,185 | $2.06B |
| geode capital management, llc | 2,660,999 | $1.50B |
| bamco inc /ny/ | 1,633,367 | $917.8M |
| bank of new york mellon corp | 1,504,532 | $845.4M |
| morgan stanley | 1,315,954 | $739.4M |
| blair william & co/il | 946,336 | $531.7M |
| northern trust corp | 911,893 | $512.4M |
Showing top 10 of 1,303 institutional holders of IDEXX LABORATORIES INC /DE. Open the full 13F history after sign-in.
Short Interest
as of May 21, 2026- % of float
- 3.0%
- Days to cover
- 3.8
- Shares short
- 2,082,179
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
IDXX short interestGovernance
Frequently asked questions
Who is the CEO of IDEXX LABORATORIES INC /DE?
Mr. Michael G. Erickson Ph.D. is the chief executive officer of IDEXX LABORATORIES INC /DE (IDXX).
Where is IDEXX LABORATORIES INC /DE headquartered?
IDEXX LABORATORIES INC /DE (IDXX) is headquartered in Westbrook, ME, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.